The efficacy and safety of omalizumab in refractory chronic spontaneous urticaria: real-life experience in Turkey.
Bulur I, Bulbul Baskan E, Ozdemir M, Balevi A, Kocatürk Göncü E, Altunay I, Gönül M, Ergin C, Ertam İ, Erdoğan HK, Bilgin M, Mustafa Teoman E.
Bulur I, et al. Among authors: erdogan hk.
Acta Dermatovenerol Alp Pannonica Adriat. 2018 Sep;27(3):121-126.
Acta Dermatovenerol Alp Pannonica Adriat. 2018.
PMID: 30244261
Free article.